Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Bacterial Conjunctivitis

In brief

This study is being conducted to evaluate the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle in the treatment of bacterial conjunctivitis. This study was conducted as a phase IIb study and continued with further enrollment as a phase III study.

Key facts

Study ID

NCT00972777

Run by

Bausch & Lomb Incorporated

People needed

474

Starts

2009-10-01

Expected to finish

2011-02-01

Last updated by the study team

2012-03-29

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are at least one year of age.
• Subjects who have a clinical diagnosis of acute bacterial conjunctivitis.
• Subjects who are willing to discontinue contact lens wear for the duration of the study.

You may not qualify if…

• Subjects who have any uncontrolled systemic disease or debilitating disease.
• Subjects with known sensitivity or contraindications to besifloxacin, fluoroquinolones or any ingredients in study drugs.
• Subjects who are expected to require treatment with any disallowed medications.

Where it is running

• Bausch & Lomb Incorporated — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.